Novo Nordisk: Reality Is Starting To Set In

aprott Novo Nordisk Stock Suffered A Rare Bear Market Novo Nordisk A/S (NVO) investors have suffered a rare bear market since the stock topped out in June 2024. As a result, the market seems primed for increasing headwinds against NVO's heightened competitive landscape. In addition, the supply shortages for GLP-1 weight loss drugs have also improved markedly. Therefore, Novo Nordisk's ability to raise prices more significantly could be impacted, even as it attempts to expand access to improve coverage.  ...